Rhythm Pharmaceuticals (RYTM) Asset Utilization Ratio (2021 - 2026)

Rhythm Pharmaceuticals (RYTM) has 6 years of Asset Utilization Ratio data on file, last reported at 0.47 in Q1 2026.

• On a quarterly basis, Asset Utilization Ratio rose 33.98% year-over-year to 0.47 in Q1 2026; TTM through Mar 2026 was 0.47, a 33.98% increase from a year earlier, with the FY2025 full-year figure at 0.43, up 21.18% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.47, up from 0.38 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for RYTM reached as high as 0.47 in Q1 2026 and fell as low as 0.02 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.23 across 5 years, with a median of 0.3 in 2024.
• Across the five-year window, Asset Utilization Ratio jumped 1179.79% in 2023 and rose 11.67% in 2025, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.02 in 2022, then soared by 1179.79% to 0.23 in 2023, then soared by 52.74% to 0.34 in 2024, then gained by 11.67% to 0.38 in 2025, then gained by 22.45% to 0.47 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.47 in Q1 2026, 0.38 in Q4 2025, and 0.4 in Q3 2025.